Related Experiment Video
Updated: Mar 6, 2026

A Mouse Model to Investigate the Role of Cancer-Associated Fibroblasts in Tumor Growth
Published on: December 22, 2020
Secreted frizzled-related protein 2-mediated cancer events: Friend or foe?
Yanhui Liu1, Qun Zhou1, Dexi Zhou1
1School of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China; Anhui Institute of Innovative Drugs, Hefei 230032, China.
Abstract:
Secreted frizzled-related protein (SFRP)2, an identified member of the SFRPs family of molecules, is often methylated in human cancers and its down-regulation is closely related to Wnt signaling activity and tumor progression. Although the blocker of the Wnt signaling has not been fully used in clinical trial, interest has been further enhanced by the realization of SFRPs' potential as targets to modulate Wnt signaling and cancer cell growth. Emerging evidence showed that SFRP2 was an anti-oncogene, however, a steady flow of research has indicated that it may also have tumor promotion effects in some cancer types. Furthermore, SFRP2 methylation was shown to accelerate cancer cell invasion and growth in tumor progression. In this review, we define recent understanding of the diverse roles of SFRP2 in tumorigenesis, and it might promote the development of novel drugs for curing cancer by targeting SFRP2.
Insights
Secreted frizzled-related protein 2 (SFRP2) methylation impacts cancer progression. This review explores SFRP2
Area of Science:
- Molecular Biology
- Oncology
- Cancer Research
Background:
- Secreted frizzled-related protein 2 (SFRP2) is frequently methylated in human cancers, leading to its down-regulation.
- SFRP2's role in Wnt signaling pathway activity and tumor progression is complex, with evidence suggesting both anti-oncogenic and tumor-promoting functions.
- Methylation of SFRP2 has been linked to accelerated cancer cell invasion and growth.
Purpose of the Study:
- To review and synthesize current understanding of SFRP2's multifaceted roles in tumorigenesis.
- To highlight the potential of SFRP2 as a therapeutic target for novel cancer treatments.
Main Methods:
- Literature review of studies investigating SFRP2's function in various cancer types.
- Analysis of research on SFRP2 methylation patterns and their correlation with cancer progression.
- Evaluation of the Wnt signaling pathway's interaction with SFRP2 in cancer development.
Main Results:
- SFRP2 exhibits dual roles in cancer, acting as an anti-oncogene in some contexts and a tumor promoter in others.
- SFRP2 down-regulation via methylation is associated with enhanced cancer cell invasion, growth, and overall tumor progression.
- Modulating Wnt signaling through SFRP2 presents a promising avenue for cancer therapy development.
Conclusions:
- SFRP2's complex involvement in tumorigenesis necessitates further investigation.
- Targeting SFRP2 offers potential for developing innovative anti-cancer drugs.
- Understanding SFRP2's precise role in different cancer types is crucial for effective therapeutic strategies.
Related Concept Videos
Canonical Wnt Signaling Pathway
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mitogens and the Cell Cycle
Cancer Cell Migration through Invadopodia
Non-Canonical Wnt Signaling Pathways

